US, Iran Trade Strikes; SK Hynix US Offering Sees Strong Investor Demand | Bloomberg Brief 07/9/2026

AstraZeneca (AZN) faces downside after a clinical trial failure; this is an idiosyncratic negative that may meaningfully pressure the stock and act as a drag on FTSE performance in the near term.

Named as a drag on FTSE due to trial failure; near-term catalyst likely negative until details or next steps are clarified. Recommendation: sell / reduce exposure while awaiting clinical updates or management guidance.

Fragmentary macro note: mentions 30-year real yields near Global Financial Crisis levels, with bond yields and JGB yields rising in tandem; implies a higher-for-longer real-rate regime and pressure on long-duration assets.

News segment discusses SK Hynix planning a record-setting first-time US share sale (~$26B), highlighting strong demand/oversubscription, the company’s dominant position in high-bandwidth memory (HBM ~57% share), and the strategic goal of getting in front of US investors/customers in the AI supply chain. Separately notes a price-target change on AMD framed as a valuation reset vs a fundamental slowdown, with AMD down on the day.

Discussion highlights Delta (DAL) reaffirming profit guidance despite fuel-cost uncertainty, with strong unit revenue driven by premium demand and corporate travel. Commentary suggests network carriers have de-risked earnings via premium cabin, loyalty, and partnerships; low-cost carriers lag in profitability. Mentions DAL positively; Southwest (LUV) still profitable; Frontier (ULCC) improving; Copa (CPA) cited as structurally higher-margin/low leverage peer.

Commentary suggests the U.S. is trying to avoid an all-out war with Iran but will sustain naval operations to keep Strait of Hormuz shipping lanes open. It also notes the U.S. revoked Iran’s ability/license to sell oil, implying tighter Iranian supply and continued geopolitical risk premium in energy/shipping. Overall implication: higher short-term oil risk premium, beneficiaries in energy and defense; losers in airlines/transport and oil-consuming industries if crude spikes.

Report says Starbucks is developing more in-house AI tools to replace software it currently buys from large enterprise vendors (mentioned: Microsoft, IBM; also Salesforce referenced by market move). The headline implies potential vendor spend displacement; the body notes IBM and Salesforce were down ~2% on the news, Microsoft marginally lower.

Bloomberg brief highlights: SK Hynix’s major U.S. listing raising ~$26.5B (largest foreign U.S. listing per segment), U.S. says Iran talks continue despite clashes, Japan sees a “triple rally” (yen stronger, yields down, equities up) amid comments urging pension funds to shift toward domestic assets, and Europe shows relative resilience with cyclicals firmer; EasyJet sees competing interest involving Apollo vs Castlelake; Vodafone sold an entire stake at a premium (supportive for the stock).

Commentary frames markets as split into “AI” vs “everything else,” noting Q1 earnings strength was concentrated in a handful of large companies (especially big tech). Mentions Mark Zuckerberg/Meta suggesting Meta might sell excess compute capacity. Also notes the Fed decision timing alongside big-tech earnings could have a disproportionate market impact.

Broadcast highlights: SK Hynix makes a major U.S. listing debut; easyJet jumps on a surprise Apollo approach (potential bidding war); Japan finance minister urges pension funds to allocate more domestically, supporting JPY; Goldman notes favorable carry-trade conditions; UAE oil output hits a record (4.1mb/d) as Brent/WTI trade ~1% lower; Nasdaq futures point ~0.5% lower after prior AI-led gains.